Cosmetic cross-reference

Fluorosalan

CAS 4776-06-1

Fluorosalan (CAS 4776-06-1) is a Phase 2 pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Fluorosalan

CAS Number

4776-06-1

UNII

80OFG3WPYD

InChIKey

VYKKDKFTDMVOBU-UHFFFAOYSA-N

ChEMBL ID

CHEMBL283552

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL283552 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 7 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	GI50	3252.6005263157895 nM	57	-
-	Potency	20160.93157894737 nM	19	-
-	MIC	0.5857142857142856 ug.mL-1	7	-
-	IC50	88.78333333333335 nM	6	-
Kappa-type opioid receptor GPCR	IC50	6.8	-	Homo sapiens
Mu-type opioid receptor GPCR	IC50	8.07	-	Mus musculus
Mu-type opioid receptor GPCR	IC50	7.92	-	Cavia porcellus

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Fluorosalan used for in pharmaceutical contexts?

Fluorosalan (CAS 4776-06-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Fluorosalan?

No adverse-event association or SIDER side-effect rows are rendered for Fluorosalan in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Fluorosalan also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Fluorosalan with EU status "prohibited".

What clinical phase is Fluorosalan in?

Fluorosalan is rendered with ChEMBL max phase 2.

What bioactivity targets are documented for Fluorosalan?

Fluorosalan has 7 bioactivity rows in this page query. Rendered target entries include Kappa-type opioid receptor, Mu-type opioid receptor.